American Oriental Bioengineering, Inc. AOBI OTC

Other OTC • Healthcare • Biotechnology • CN • USD

SharesGrow Score

27/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

American Oriental Bioengineering, Inc. (AOBI) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 26/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

PAST

50/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

29/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — AOBI

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-781.24

Book Value / Share$0.00

Revenue / Share$1,898.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2003	$150.30	$20.86M	$4.6M	22.1%
2004	$230.46	$31.97M	$7.77M	24.3%
2005	$310.62	$54.73M	$13.43M	24.5%
2006	$460.92	$110.18M	$29.2M	26.5%
2007	$611.22	$160.48M	$43.29M	27%
2008	$611.22	$264.64M	$47.06M	17.8%
2009	$1,062.12	$296.15M	$41.42M	14%
2010	$185.37	$305.94M	$14.09M	4.6%
2011	$-901.80	$212.69M	$-68.49M	-32.2%
2012	$-781.24	$145.1M	$-59.71M	-41.2%